Posts

Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter

Provepharm Inc. Issues Recall of One Lot of Phenylephri...

May 12, 2025 0

Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Prov...

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis

Drug Safety Communication: Copaxone, Glatopa (glatirame...

May 12, 2025 0

Audience: Patient, Caregiver, Health Care Professional, Pharmacy, Neurology ISSU...

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System

Alvogen Issues Voluntary Nationwide Recall for One Lot ...

May 12, 2025 0

Audience: Consumer, Health Professional, Pharmacy January 31, 2025 – Morristown,...

ICU Medical Issues Nationwide Recall of Potassium Chloride Injection, 20 mEq and Potassium Chloride Injection, 10 mEq Due to Mislabeling

ICU Medical Issues Nationwide Recall of Potassium Chlor...

May 12, 2025 0

Audience: Consumer, Health Professional, Pharmacy February 13, 2025 LAKE FOREST,...

Natural Dior LLC Issues Voluntary Nationwide Recall of Vitafer-L Gold Liquid Due to Presence of Undeclared Tadalafil

Natural Dior LLC Issues Voluntary Nationwide Recall of ...

May 12, 2025 0

Audience: Consumer Natural Dior LLC (USA) – February 25, 2025 – Natural ...

CAPS Issues Recall of Phenylephrine 40 mg Added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bags Due to Visible Black Particulate Matter in a Single-Sealed Vial

CAPS Issues Recall of Phenylephrine 40 mg Added to 0.9%...

May 12, 2025 0

Audience: Pharmacy, Health Care Professional February 24, 2025 – Bethlehem, PA. ...

Limited Number of Voluntary Recalls Initiated after FDA Testing of Acne Products for Benzene

Limited Number of Voluntary Recalls Initiated after FDA...

May 12, 2025 0

Audience: Consumer, Pharmacy March 11, 2025 -- FDA is alerting the public and in...

Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Due to Increased Reports of Allergic/Hypersensitivity Reactions

Voluntary Lot Withdrawals of Immune Globulin Intravenou...

May 12, 2025 0

Audience: Patient, Health Professional, Pharmacy, Immunology March 10, 2025 -- A...

One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalaﬁl

One Source Nutrition, Inc. Issues Voluntary Nationwide ...

May 12, 2025 0

Audience: Consumer Benton, Arkansas – 03/03/2025 –One Source Nutrition is volunt...

Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag

Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam...

May 12, 2025 0

Audience: Pharmacy, Health Care Professional March 13, 2025 -- Dr. Reddy’s Labor...

FDA Advises Consumers Not to Inhale Nitrous Oxide Products

FDA Advises Consumers Not to Inhale Nitrous Oxide Products

May 12, 2025 0

Audience: Consumer, Health Professional, Pulmonology March 14, 2025 -- FDA advis...

FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain

FDA Warns Consumers Not to Use Counterfeit Ozempic (sem...

May 12, 2025 0

Audience: Consumers April 14, 2025 -- FDA was notified by Novo Nordisk on April ...

Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter

Amneal Pharmaceutical LLC Issues a Nationwide Recall of...

May 12, 2025 0

Audience: Consumer, Health Professional, Pharmacy April 18, 2025 -- Bridgewater,...

FDA Alerts Health Care Providers, Compounders and Consumers of Potential Risks Associated with Compounded Topical Finasteride Products

FDA Alerts Health Care Providers, Compounders and Consu...

May 12, 2025 0

Audience: Health Care Providers, Compounders, Consumers April 22, 2025 -- FDA ha...

AI Screening for Opioid Use Disorder Associated with Fewer Hospital Readmissions

AI Screening for Opioid Use Disorder Associated with Fe...

May 12, 2025 0

April 3, 2025 -- An artificial intelligence (AI)-driven screening tool, develope...

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

Biogen’s Investigational Tau-Targeting Therapy BIIB080 ...

May 12, 2025 0

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) ...

Combination Immunotherapy Shrank a Variety of Metastatic Gastrointestinal Cancers

Combination Immunotherapy Shrank a Variety of Metastati...

May 12, 2025 0

April 1, 2025 -- A new form of tumor infiltrating lymphocyte (TIL) therapy, a fo...

Genentech and Roche Present Novel Therapeutic and Diagnostic Advancements in Alzheimer’s at AD/PD 2025

Genentech and Roche Present Novel Therapeutic and Diagn...

May 12, 2025 0

South San Francisco, CA -- April 3, 2025 -- Genentech, a member of the Roche Gro...

BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program

BeiGene Provides Update on the Ociperlimab (BGB-A1217) ...

May 12, 2025 0

SAN CARLOS, Calif.--(BUSINESS WIRE) April 3, 2025 -- BeiGene, Ltd. (NASDAQ: ONC;...

Rilzabrutinib Granted Orphan Drug Designation in the US for Two Rare Diseases with No Approved Medicines

Rilzabrutinib Granted Orphan Drug Designation in the US...

May 12, 2025 0

Paris, April 3, 2025. The US Food and Drug Administration (FDA) has granted orph...

Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor VVD-159642 for Treatment of Advanced Solid Tumors

Vividion Therapeutics Doses First Patient in Phase I St...

May 12, 2025 0

San Diego, CA, USA, Berlin, Germany, April 3, 2025 – Vividion Therapeutics, Inc....

Icotrokinra Results Show 75% of Adolescents with Plaque...

May 12, 2025 0

SPRING HOUSE, Pa. (April 10, 2025) – Johnson & Johnson (NYSE: JNJ) today announc...

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

Allogene Granted Three U.S. FDA Fast Track Designations...

May 12, 2025 0

SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Allogene Therape...

Theravance Biopharma Presents Two New Ampreloxetine Analyses

Theravance Biopharma Presents Two New Ampreloxetine Ana...

May 12, 2025 0

DUBLIN, April 7, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Bi...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.